Published in NMR Biomed on September 23, 2011
Metabolic response of glioma to dichloroacetate measured in vivo by hyperpolarized (13)C magnetic resonance spectroscopic imaging. Neuro Oncol (2013) 1.08
Regression of glioma tumor growth in F98 and U87 rat glioma models by the Nitrone OKN-007. Neuro Oncol (2013) 0.84
Metabolic profiling of dividing cells in live rodent brain by proton magnetic resonance spectroscopy (1HMRS) and LCModel analysis. PLoS One (2014) 0.82
High-field small animal magnetic resonance oncology studies. Phys Med Biol (2013) 0.81
The role of astrocytes in CNS tumors: pre-clinical models and novel imaging approaches. Front Cell Neurosci (2013) 0.81
Magnetic resonance spectroscopy for detection of choline kinase inhibition in the treatment of brain tumors. Mol Cancer Ther (2015) 0.81
Magnetic resonance spectroscopy - Revisiting the biochemical and molecular milieu of brain tumors. BBA Clin (2016) 0.80
The orthotopic xenotransplant of human glioblastoma successfully recapitulates glioblastoma-microenvironment interactions in a non-immunosuppressed mouse model. BMC Cancer (2014) 0.80
Imaging the intratumoral-peritumoral extracellular pH gradient of gliomas. NMR Biomed (2016) 0.79
Motif mimetic of epsin perturbs tumor growth and metastasis. J Clin Invest (2015) 0.79
Towards longitudinal mapping of extracellular pH in gliomas. NMR Biomed (2016) 0.79
Preclinical (1)H-MRS neurochemical profiling in neurological and psychiatric disorders. Bioanalysis (2012) 0.78
Inhibition of Pediatric Glioblastoma Tumor Growth by the Anti-Cancer Agent OKN-007 in Orthotopic Mouse Xenografts. PLoS One (2015) 0.77
Chemical exchange rotation transfer imaging of intermediate-exchanging amines at 2 ppm. NMR Biomed (2017) 0.76
MR image-guided delivery of cisplatin-loaded brain-penetrating nanoparticles to invasive glioma with focused ultrasound. J Control Release (2017) 0.75
The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol (2007) 49.11
Creatine and creatinine metabolism. Physiol Rev (2000) 5.76
Automatic, localized in vivo adjustment of all first- and second-order shim coils. Magn Reson Med (1993) 5.48
N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol (2007) 4.63
In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time. Magn Reson Med (1999) 4.26
A novel one-armed anti-c-Met antibody inhibits glioblastoma growth in vivo. Clin Cancer Res (2006) 2.48
Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med (2003) 2.44
Toward an in vivo neurochemical profile: quantification of 18 metabolites in short-echo-time (1)H NMR spectra of the rat brain. J Magn Reson (1999) 2.42
Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res (1993) 2.39
Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. AJNR Am J Neuroradiol (2001) 2.34
Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. J Neurooncol (1998) 2.34
Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas. J Neurooncol (2009) 2.33
High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology (2002) 2.22
Magnetic resonance spectroscopy of the human brain. Anat Rec (2001) 2.18
Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor. Proc Natl Acad Sci U S A (1996) 2.02
Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion. Cell Tissue Res (2002) 1.91
Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology (2002) 1.91
Detailed characterization of the mouse glioma 261 tumor model for experimental glioblastoma therapy. Cancer Sci (2006) 1.74
A constrained least-squares approach to the automated quantitation of in vivo ¹H magnetic resonance spectroscopy data. Magn Reson Med (2011) 1.54
Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomas. NMR Biomed (2006) 1.38
1H MRS detects polyunsaturated fatty acid accumulation during gene therapy of glioma: implications for the in vivo detection of apoptosis. Nat Med (1999) 1.38
1H MR spectroscopy of brain tumours and masses. NMR Biomed (2003) 1.34
The clinical value of proton magnetic resonance spectroscopy in adult brain tumours. Clin Radiol (2007) 1.26
Relationship of MR-derived lactate, mobile lipids, and relative blood volume for gliomas in vivo. AJNR Am J Neuroradiol (2005) 1.22
Complications of CT-guided stereotactic biopsy of intra-axial brain lesions. J Neurosurg (1994) 1.19
Hypoxia-regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiforme. Cancer (2008) 1.18
Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging. Radiology (2006) 1.17
Advanced MRI of adult brain tumors. Neurol Clin (2007) 1.14
1H MRS of high grade astrocytomas: mobile lipid accumulation in necrotic tissue. NMR Biomed (1994) 1.13
The 9L rat brain tumor: description and application of an animal model. J Neurol (1981) 1.11
Low-grade gliomas and focal cortical developmental malformations: differentiation with proton MR spectroscopy. Radiology (2004) 1.11
Primary glia expressing the G93A-SOD1 mutation present a neuroinflammatory phenotype and provide a cellular system for studies of glial inflammation. J Neuroinflammation (2006) 1.11
In vivo single-voxel proton MR spectroscopy in the differentiation of high-grade gliomas and solitary metastases. Clin Radiol (2004) 1.10
Linear discriminant analysis of brain tumour (1)H MR spectra: a comparison of classification using whole spectra versus metabolite quantification. NMR Biomed (2007) 1.06
Genetic characterization of commonly used glioma cell lines in the rat animal model system. Neurosurg Focus (2005) 1.01
Phenyl-tert-butylnitrone induces tumor regression and decreases angiogenesis in a C6 rat glioma model. Free Radic Biol Med (2007) 1.01
Glioma morphology and tumor-induced vascular alterations revealed in seven rodent glioma models by in vivo magnetic resonance imaging and angiography. J Magn Reson Imaging (2010) 1.00
Diagnostic potential of short echo time MR spectroscopy of gliomas with single-voxel and point-resolved spatially localised proton spectroscopy of brain. Neuroradiology (2001) 1.00
Improved analysis of 1H-MR spectra in the presence of mobile lipids. Magn Reson Med (2001) 0.99
Magnetic resonance imaging of ethyl-nitrosourea-induced rat gliomas: a model for experimental therapeutics of low-grade gliomas. J Neurooncol (2001) 0.99
Regional measurements of blood-to-tissue transport in experimental RG-2 rat gliomas. Cancer Res (1983) 0.97
Relationships among lactate concentration, blood flow and histopathologic profiles in rat C6 glioma. NMR Biomed (1996) 0.96
An algorithm for the automated quantitation of metabolites in in vitro NMR signals. Magn Reson Med (2006) 0.96
Correlations between in vivo (1)H MRS and ex vivo (1)H HRMAS metabolite measurements in adult human gliomas. J Magn Reson Imaging (2010) 0.96
Early detection of radiation therapy response in non-Hodgkin's lymphoma xenografts by in vivo 1H magnetic resonance spectroscopy and imaging. NMR Biomed (2010) 0.95
Evidence that mobile lipids detected in rat brain glioma by 1H nuclear magnetic resonance correspond to lipid droplets. Cancer Res (1997) 0.95
Monitoring of gliomas in vivo by diffusion MRI and (1)H MRS during gene therapy-induced apoptosis: interrelationships between water diffusion and mobile lipids. NMR Biomed (2009) 0.92
Could assessment of glioma methylene lipid resonance by in vivo (1)H-MRS be of clinical value? Br J Radiol (2003) 0.90
2D-spatial/2D-spectral spectroscopic imaging of intracerebral gliomas in rat brain. Magn Reson Med (2000) 0.89
Failed stereotactic biopsy in a series of 518 cases. Stereotact Funct Neurosurg (1995) 0.89
Influence of measured and simulated basis sets on metabolite concentration estimates. NMR Biomed (2008) 0.88
Characterization of N-nitrosourea-induced tumors of the nervous system; their prospective value for studies of neurocarcinogenesis and brain tumor therapy. Toxicol Pathol (1990) 0.88
In vivo research in astrocytoma cell proliferation with 1H-magnetic resonance spectroscopy: correlation with histopathology and immunohistochemistry. Neuroradiology (2006) 0.88
In vivo, ex vivo, and in vitro one- and two-dimensional nuclear magnetic resonance spectroscopy of an intracerebral glioma in rat brain: assignment of resonances. J Neurochem (1994) 0.87
MRS of oligodendroglial tumors: correlation with histopathology and genetic subtypes. Neurology (2005) 0.87
Two distinct tumor phenotypes isolated from glioblastomas show different MRS characteristics. NMR Biomed (2008) 0.87
Apparent T(2) relaxation times of lipid and macromolecules: a study of high-grade tumor spectra. J Magn Reson Imaging (2008) 0.86
Intratumoral lipids in 1H MRS in vivo in brain tumors: experience of the Siemens cooperative clinical trial. Anticancer Res (1996) 0.85
Impact of morphology and biology on the prognosis of patients with gliomas. Medicina (Kaunas) (2004) 0.85
Identification of mobile cholesterol compounds in experimental gliomas by (1)H MRS in vivo: effects of ganciclovir-induced apoptosis on lipids. FEBS Lett (2006) 0.84
In vivo establishment of T98G human glioblastoma. Methods Find Exp Clin Pharmacol (1999) 0.84
Quantitative assessment of gliomas by proton magnetic resonance spectroscopy. Anticancer Res (2007) 0.83
Prognostic relevance of cell proliferation markers and DNA-ploidy in gliomas. Acta Neurochir (Wien) (1998) 0.82
Spatially localized in vivo 1H magnetic resonance spectroscopy of an intracerebral rat glioma. Magn Reson Med (1992) 0.81
Diagnostic value of stereotactic biopsy of cerebral lesions in patients with AIDS. Acta Neurochir (Wien) (1995) 0.81
Proton MR spectroscopy of experimental brain tumors in vivo. Acta Neurochir Suppl (Wien) (1994) 0.80
In vivo single voxel 1H MRS of glial brain tumors: correlation with tissue histology and in vitro MRS. Int J Oncol (1998) 0.80
In vivo proton MR spectroscopy: the diagnostic possibilities of lipid resonances in brain tumors. Anticancer Res (1996) 0.79
Proton (1H) MR spectroscopy for routine diagnostic evaluation of brain lesions. Acta Radiol (1997) 0.76
Mesothelin is overexpressed in pancreaticobiliary adenocarcinomas but not in normal pancreas and chronic pancreatitis. Am J Clin Pathol (2005) 2.21
Endothelial epsin deficiency decreases tumor growth by enhancing VEGF signaling. J Clin Invest (2012) 1.87
Sigma receptors: potential medications development target for anti-cocaine agents. Eur J Pharmacol (2003) 1.79
DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanism. Cancer Res (2011) 1.73
Nitrones as therapeutics. Free Radic Biol Med (2008) 1.35
Silencing of hypoxia inducible factor-1alpha by RNA interference attenuates human glioma cell growth in vivo. Clin Cancer Res (2007) 1.31
Computational analysis of biological functions and pathways collectively targeted by co-expressed microRNAs in cancer. BMC Bioinformatics (2007) 1.21
Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1alpha. Cancer Chemother Pharmacol (2010) 1.21
Hypoxia-regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiforme. Cancer (2008) 1.18
Early growth response gene-1 regulates hypoxia-induced expression of tissue factor in glioblastoma multiforme through hypoxia-inducible factor-1-independent mechanisms. Cancer Res (2006) 1.13
Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS). Cancer (2007) 1.13
Multiinstitutional validation of the University of California at San Francisco Low-Grade Glioma Prognostic Scoring System. Clinical article. J Neurosurg (2009) 1.12
Translational research involving oxidative stress and diseases of aging. Free Radic Biol Med (2011) 1.10
Modification of lupus-associated 60-kDa Ro protein with the lipid oxidation product 4-hydroxy-2-nonenal increases antigenicity and facilitates epitope spreading. Free Radic Biol Med (2005) 1.09
Epidermal growth factor receptor gene amplification and protein expression in glioblastoma multiforme: prognostic significance and relationship to other prognostic factors. Appl Immunohistochem Mol Morphol (2006) 1.09
Transient postictal MRI changes in patients with brain tumors may mimic disease progression. Surg Neurol (2006) 1.08
Early myocardial dysfunction in streptozotocin-induced diabetic mice: a study using in vivo magnetic resonance imaging (MRI). Cardiovasc Diabetol (2007) 1.06
Safety and feasibility of convection-enhanced delivery of Cotara for the treatment of malignant glioma: initial experience in 51 patients. Neurosurgery (2005) 1.04
Identification of hypoxia-induced genes in a malignant glioma cell line (U-251) by cDNA microarray analysis. Neurosurg Rev (2007) 1.04
WHO Grade II and III supratentorial hemispheric ependymomas in adults: case series and review of treatment options. J Neurooncol (2008) 1.03
Variations of disseminated choroid plexus papilloma: 2 case reports and a review of the literature. Surg Neurol (2006) 1.03
Immuno-spin trapping of protein and DNA radicals: "tagging" free radicals to locate and understand the redox process. Free Radic Biol Med (2009) 1.01
Phenyl-tert-butylnitrone induces tumor regression and decreases angiogenesis in a C6 rat glioma model. Free Radic Biol Med (2007) 1.01
Glioma morphology and tumor-induced vascular alterations revealed in seven rodent glioma models by in vivo magnetic resonance imaging and angiography. J Magn Reson Imaging (2010) 1.00
Dynamic changes of sandy land in northwest of Beijing, China. Environ Monit Assess (2006) 1.00
Molecular genetics of meningiomas. Neurosurg Focus (2005) 1.00
Subependymomas: an analysis of clinical and imaging features. Neurosurgery (2006) 1.00
LINE-1 hypomethylation in a choline-deficiency-induced liver cancer in rats: dependence on feeding period. J Biomed Biotechnol (2006) 1.00
Surgical considerations regarding giant dilations of the perivascular spaces. J Neurosurg (2004) 1.00
Lipotoxicity in HepG2 cells triggered by free fatty acids. Am J Transl Res (2011) 0.96
Brain injury: neuro-inflammation, cognitive deficit, and magnetic resonance imaging in a model of blast induced traumatic brain injury. J Neurotrauma (2013) 0.96
Role of stereotactic radiosurgery in the treatment of brain metastases. Am J Clin Oncol (2005) 0.96
Visualization of the protective ability of a free radical trapping compound against rat C6 and F98 gliomas with diffusion tensor fiber tractography. J Magn Reson Imaging (2008) 0.96
Hydroxyapatite coating on Ti6Al4V alloy by a sol-gel method. J Mater Sci Mater Med (2007) 0.95
Dose fractionation in stereotactic radiotherapy for parasellar meningiomas: radiobiological considerations of efficacy and optic nerve tolerance. J Neurosurg (2004) 0.95
The nuclear translocation of endostatin is mediated by its receptor nucleolin in endothelial cells. Angiogenesis (2012) 0.95
Anti-cancer activity of nitrones and observations on mechanism of action. Anticancer Agents Med Chem (2011) 0.95
Multiparametric assessment of the anti-glioma properties of OKN007 by magnetic resonance imaging. J Magn Reson Imaging (2010) 0.95
Electrochemical stability of nanometer-scale Pt particles in acidic environments. J Am Chem Soc (2010) 0.94
[Study on material basis of Dracocephalum moldavica for protecting cardiomyocyte against hypoxia/reoxygenation injury by traditional Chinese medicine serum chemical and pharmacological methods]. Zhongguo Zhong Yao Za Zhi (2012) 0.94
Biochemotherapy of metastatic melanoma in patients with or without recently diagnosed brain metastases. Cancer (2007) 0.94
Klotho suppresses renal tubulo-interstitial fibrosis by controlling basic fibroblast growth factor-2 signalling. J Pathol (2014) 0.93
Celecoxib inhibits meningioma tumor growth in a mouse xenograft model. Cancer (2007) 0.93
Dried plum polyphenols inhibit osteoclastogenesis by downregulating NFATc1 and inflammatory mediators. Calcif Tissue Int (2008) 0.92
Oligodendroglioma and juvenile pilocytic astrocytoma presenting as synchronous primary brain tumors. Case report with histological and molecular differentiation of the tumors and review of the literature. J Neurosurg (2004) 0.92
Treatment-related brain tumor imaging changes: So-called "pseudoprogression" vs. tumor progression: Review and future research opportunities. Surg Neurol Int (2013) 0.92
Comparison of 18F-fluorodeoxyglucose and 18F-fluorothymidine PET in differentiating radiation necrosis from recurrent glioma. Clin Nucl Med (2012) 0.92
Lymphatic vessel density and function in experimental bladder cancer. BMC Cancer (2007) 0.91
A comparison of the cell lines used in meningioma research. Surg Neurol (2008) 0.91
ELTD1, a potential new biomarker for gliomas. Neurosurgery (2013) 0.91
Aberrant signaling pathways in meningiomas. J Neurooncol (2010) 0.91
In vivo detection of inducible nitric oxide synthase in rodent gliomas. Free Radic Biol Med (2009) 0.91
p21WAF1/CIP1 gene transcriptional activation exerts cell growth inhibition and enhances chemosensitivity to cisplatin in lung carcinoma cell. BMC Cancer (2010) 0.91
Effects of PBN and OKN007 in rodent glioma models assessed by 1H MR spectroscopy. Free Radic Biol Med (2011) 0.90
Preliminary use of differential scanning calorimetry of cerebrospinal fluid for the diagnosis of glioblastoma multiforme. J Neurooncol (2011) 0.90
A practical review of prognostic correlations of molecular biomarkers in glioblastoma. Neurosurg Focus (2015) 0.90
A novel model of intracranial meningioma in mice using luciferase-expressing meningioma cells. Laboratory investigation. J Neurosurg (2008) 0.89
Conformity of LINAC-based stereotactic radiosurgery using dynamic conformal arcs and micro-multileaf collimator. Int J Radiat Oncol Biol Phys (2008) 0.88
Meningioma of the jugular foramen: glomus jugulare mimic and surgical challenge. Laryngoscope (2004) 0.88
Peritumoral edema after stereotactic radiosurgery for intracranial meningiomas and molecular factors that predict its development. J Neurooncol (2007) 0.88
Loureirin B inhibits fibroblast proliferation and extracellular matrix deposition in hypertrophic scar via TGF-β/Smad pathway. Exp Dermatol (2015) 0.87
Molecular MRI assessment of vascular endothelial growth factor receptor-2 in rat C6 gliomas. J Cell Mol Med (2011) 0.87
Multidisciplinary treatment of brain metastases derived from clear cell renal cancer incorporating stereotactic radiosurgery. Cancer (2008) 0.87
Rapamycin promotes podocyte autophagy and ameliorates renal injury in diabetic mice. Mol Cell Biochem (2014) 0.87
Sepsis-associated encephalopathy: a magnetic resonance imaging and spectroscopy study. J Cereb Blood Flow Metab (2009) 0.87
Combined molecular MRI and immuno-spin-trapping for in vivo detection of free radicals in orthotopic mouse GL261 gliomas. Biochim Biophys Acta (2013) 0.86
In vivo imaging of immuno-spin trapped radicals with molecular magnetic resonance imaging in a diabetic mouse model. Diabetes (2012) 0.86
Heat shock cognate 70 regulates the translocation and angiogenic function of nucleolin. Arterioscler Thromb Vasc Biol (2012) 0.86
Experimental validation of 5 in-silico predicted glioma biomarkers. Neuro Oncol (2013) 0.86
Comparative Transcriptional Profiling of Two Contrasting Barley Genotypes under Salinity Stress during the Seedling Stage. Int J Genomics (2013) 0.86
New approaches for the treatment of refractory meningiomas. Cancer Control (2003) 0.85
Molecular magnetic resonance imaging approaches used to aid in the understanding of angiogenesis in vivo: implications for tissue engineering. Tissue Eng Part A (2010) 0.85